Differential effects of human and plant N-acetylglucosaminyltransferase I (GnTI) in plants by Henquet, M.G.L. et al.
ORIGINAL PAPER
Differential effects of human and plant
N-acetylglucosaminyltransferase I (GnTI) in plants
Maurice Henquet • Bas Heinhuis • Jan Willem Borst •
Jochem Eigenhuijsen • Marie¨lle Schreuder •
Dirk Bosch • Alexander van der Krol
Received: 26 February 2009 / Accepted: 27 September 2009
 The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract In plants and animals, the first step in
complex type N-glycan formation on glycoproteins is
catalyzed by N-acetylglucosaminyltransferase I
(GnTI). We show that the cgl1-1 mutant of Arabidop-
sis, which lacks GnTI activity, is fully complemented
by YFP-labeled plant AtGnTI, but only partially
complemented by YFP-labeled human HuGnTI and
that this is due to post-transcriptional events. In
contrast to AtGnTI-YFP, only low levels of HuG-
nTI-YFP protein was detected in transgenic plants. In
protoplast co-transfection experiments all GnTI-YFP
fusion proteins co-localized with a Golgi marker
protein, but only limited co-localization of AtGnTI
and HuGnTI in the same plant protoplast. The partial
alternative targeting of HuGnTI in plant protoplasts
was alleviated by exchanging the membrane-anchor
domain with that of AtGnTI, but in stably transformed
cgl1-1 plants this chimeric GnTI still did not lead to
full complementation of the cgl1-1 phenotype. Com-
bined, the results indicate that activity of HuGnTI in
plants is limited by a combination of reduced protein
stability, alternative protein targeting and possibly to
some extend to lower enzymatic performance of the
catalytic domain in the plant biochemical
environment.
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Introduction
In eukaryotes many of the secreted proteins are
modified by N-glycosylation upon import into the
endoplasmatic reticulum (ER). The N-glycan biosyn-
thesis starts at the cytoplasmic side of the ER, where
sequentially two N-acetylglucosamine and five man-
nose residues are transferred onto the lipid dolichol-P,
giving rise to the Man5GlcNAc2-PP-Dol intermediate.
Then, in a process not well understood, Man5Glc-
NAc2-PP-Dol flips to the luminal side of the ER, where
four mannose and three glucose residues are stepwise
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added by distinctive glycosyl transferases (Snider et al.
1980; Helenius and Aebi 2002), leading to the lipid-
bound precursor oligosaccharide Glc3Man9GlcNAc2.
This lipid-linked glycan-moiety is then transferred en
bloc by the multisubunit oligosaccharyltransferase
complex (OST) to the asparagine (N) residues in the
consensus N-glycosylation sequence N-X-S/T of
nascent protein chains during their translocation into
the ER (Kornfeld and Kornfeld 1985). After removal
of the three glucose residues and all four a (1,2)-linked
mannose residues, the glycan can be further modified
by trimming and addition reactions, leading to the so-
called complex type glycans.
The first obligatory step in complex type glycans
formation in higher eukaryotes, such as plants and
animals, is catalyzed by the enzyme N-acetylglucosa-
minyltransferase I (GnTI) (Kornfeld and Kornfeld
1985). Different GnTI genes, originating from animal
and plant species have been identified (Kumar et al.
1990; Sarkar et al. 1991; Pownall et al. 1992; Fukada
et al. 1994; Puthalakath et al. 1996; Schachter et al.
1997; Strasser et al. 1999; Wenderoth and von
Schaewen 2000). All these GnTI genes encode a type
II membrane protein, characterized by an N-terminal
short cytoplasmic tail, a transmembrane anchor
domain, a luminal stem region (combined called the
CTS domain) and a luminal catalytic domain at the C-
terminus (Kornfeld and Kornfeld 1985). The human
GnTI (HuGnTI) has been shown to localize to the
medial and trans Golgi in human cell lines (Burke et al.
1994; Grabenhorst and Conradt 1999). In contrast, the
GnTI from N. tabacum was shown to localise to both
the ER and cis-half of the Golgi bodies (Saint-Jore-
Dupas et al. 2006).
Previously, an EMS mutant of Arabidopsis was
identified, which lacks complex glycans due to a point-
mutation in Arabidopsis GnTI (AtGnTI) (complex-
glycan-less: cgl1-1; von Schaewen et al. 1993; Strasser
et al. 2005). The single point mutation in AtGnTI
resulted in a novel N-glycosylation consensus site and
a disruption of a highly conserved SQD motif present
in all GnTI amino acid sequences characterized so far.
This Arabidopsis cgl1-1 mutant was used for comple-
mentation studies by Gomez and Chrispeels (1994),
who generated cgl1-1 calli transformed with the
HuGnTI gene. Enzymatic assays of different fractions
from a density gradient indicated that both in wild-type
and in complemented cgl1-1 plant cells, human and
plant GnTI associated with the fractions which are
typical for Golgi membranes. This indicated that also
in plants the HuGnTI localizes to the Golgi system
(Gomez and Chrispeels 1994). However, the comple-
mentation of the glycosylation defect of cgl1-1 by
HuGnTI was very poor and the total enzyme activity
extracted from transformed cgl1-1 callus was less than
10% of GnTI enzyme activity extracted from wild-type
plant cells. Strasser et al. (2005) used a chimeric GnTI
construct for complementation of the cgl1-1 mutant.
This construct encodes the rabbit GnTI catalytic
domain fused to the CTS region of the plant GnTI. In
this case complementation resulted in nearly normal
levels of complex N-glycans, however it was not
investigated if and why there is a difference in
complementation efficiency in Arabidopsis cgl1-1
between plant and mammalian GnTI.
Manipulation of glycosylation in plants with mam-
malian glycosyltransferases is used for ‘humanizing’
the N-glycans on therapeutic proteins that may be
produced in plants. However, the activity of mamma-
lian glycosyltransferases in plants is still unpredictable
as was the case for expression of human GnTI in the
Arabidopsis cgl1-1 mutant (Gomez and Chrispeels
1994). Also unexpected were the entirely different
galactosylated N-glycan structures observed when two
variants of naturally occurring human galac-
tosyltransferases were expressed in tobacco (Palacpac
et al. 1999; Bakker et al. 2001). These observations
show that knowledge is lacking to reliably predict the
consequences of introducing heterologous glycosyl-
transferases in plants on N-glycosylation. We therefore
decided to more thoroughly investigate the differences
between expression of the human and Arabidopsis
GnTI enzyme in plants. We confirmed the low
complementation potential of human GnTI in plants
and show that a combination of reduced protein
stability, reduced catalytic activity and partial alterna-
tive sub-cellular targeting, all contribute to the overall
low activity of HuGnTI in plants.
Results
Sequence comparison of human and plant GnTI
Comparison of the Arabidopsis and human GnTI
amino acid sequence shows a low homology at the
cytoplasmic, transmembrane and stem region (CTS:
12% sequence identity), but a higher conservation in
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the catalytic domain (38% sequence identity)
(Fig. 1). In contrast to the mammalian GnTIs, which
do not have an N-glycosylation site, the plant GnTI
sequences identified to date contain one putative N-
glycosylation site. However, the location of the N-
glycosylation site in tobacco and potato GnTI differs
from that in Arabidopsis GnTI (Wenderoth and von
Schaewen 2000). The hydrophobic transmembrane
anchor domain of plant and human GnTI predicted by
HMMTOP V2 (Tusnady and Simon 2001), is at the
same relative position, but the transmembrane
domain for the human GnTI is predicted to be
slightly larger. The size of the transmembrane
domain may be of influence for the sub-cellular
localization of the protein, as indications (from
mammalian cells) are that membrane thickness
increases from ER to Golgi (Grabenhorst and Conradt
1999; Brandizzi et al. 2002; Neumann et al. 2003;
Saint-Jore-Dupas et al. 2006). In addition, analysis of
the HuGnTI and AtGnTI signal peptide sequences in
the plant version of SignalP showed a probability of
0,068 for signal peptide cleavage of AtGnTI (position
26) and a probability of 0,472 for signal peptide
cleavage of the HuGnTI (position 35). Cleavage of
mammalian GnTI in a heterologous host was indeed
demonstrated for the rat GnTI (SignalP probability
0,229 at position 35) in Saccharomyces cerevisiae
cells (Yoshida et al. 1999).
Different levels of complementation in the cgl1-1
lines with plant, human or chimeric GnTI
Expression constructs were made with the HuGnTI or
AtGnTI gene and a Chimeric GnTI (ChGnTI) gene,
encoding the Arabidopsis CTS domain (amino acid
residues 1–102) and the human catalytic domain
(amino acid residues 102–445). At the 30 end, the
GnTI coding sequences were fused in frame to the
coding sequence of fluorescence marker sequences
(YFP or CFP), to facilitate detection in plant cells.
The coding sequences were put under control of the
Cauliflower Mosaic Virus 35S promoter in the binary
vector pBinplus (van Engelen et al. 1995) and
Arabidopsis cgl1-1 mutant plants were transformed
using the Agrobacterium tumefaciens floral dip
method (Clough and Bent 1998). Transgenic plants
were selected by germinating seeds on medium
containing kanamycin, which yielded for each con-
struct at least nine independently transformed plants.
First, the average level of functional complemen-
tation in each set of transformants was determined.
Proteins extracted from individual primary transfor-
mants and wild-type plants were probed in an Elisa
assay with serum directed at plant complex glycans,
to determine the level of complementation towards
proteins with complex type glycans in each line. The
results show that the average level of proteins with
complex glycans was similar to wild-type in the cgl1-
1 plants expressing the AtGnTI-YFP (AtGnTIcgl) or
ChGnTI-YFP (ChGnTIcgl), but low in cgl1-1 plants
expressing the HuGnTI-YFP (HuGnTIcgl) (Fig. 2).
From each set of transformants, plants with a single
locus insert were identified by segregation analysis of
T2 seedlings on medium containing kanamycin. For
each of the constructs three independent single-locus-
insert homozygous lines were developed, with highest,
intermediate and with low level of complementation.
Progeny seedlings from these homozygous lines were
analyzed for levels of glycoproteins modified with
complex glycans, both by western blots analysis and by
AtGnTI  1   MARISCDLRFLLIPAAFMFIYIQMRLFQTQSQYADRLSSAIESENHCTSQMRGLIDEVSIKQSRIVALEDMKNRQDEELVQLKDLIQTFE
huGnTI  1   MLKKQSAGLVLWGAILFVAWNALLLLFFWTRPAPGRPPSVSALDGDPASLTREVIRLAQDAEVELERQRGLLQQIGDALSSQRGRVPTAA
AtGnTI  91  KKGIAKLTQGGQMPVAAVVVMACSRADYLERTVKSVLTYQTPVASKYPLFISQDGSDQAVKSKSLSYN-QLTYMQHLDFEPVVTERPG-E
huGnTI  91  PPAQPRVPVTPAPAVIPILVIACDRS--TVRRCLDKLLHYRPSAELFPIIVSQDCGHEETAQAIASYGSAVTHIRQPDLSSIAVPPDHRK
AtGnTI  179 LTAYYKIARHYKWALDQLFYKHKFSRVIILEDDMEIAPDFFDYFEAAASLMDRDKTIMAASSWNDNGQKQFVHD--PYALYRSDFFPGLG
huGnTI  179 FQGYYKIARHYRWALGQVFRQFRFPAAVVVEDDLEVAPDFFEYFRATYPLLKADPSLWCVSAWNDNGKEQMVDASRPELLYRTDFFPGLG
* 
AtGnTI  267 WMLKRSTWDELSPKWPKAYWDDWLRLKENHKGRQFIRPEVCRTYNFGEHGSSLGQFFSQYLEPIKLNDVTVDWKAKDLGYLTEGNYTKYF
huGnTI  269 WLLLAELWAELEPKWPKAFWDDWMRRPEQRQGRACIRPEISRTMTFGRKGVSHGQFFDQHLKFIKLNQQFVHFTQLDLSYLQREAYDRDF
AtGnTI  357 SGLVRQARPIQGSDLVLKAQNIKDDVRIRYKDQVEFERIAGEFGIFEEWKDGVPRTAYKGVVVFRIQTTRRVFLVGPDSVMQLGIRNS 
huGnTI  359 LARVYGAPQLQVEKVRTNDRKELGEVRVQYTGRDSFKAFAKALGVMDDLKSGVPRAGYRGIVTFQFRG-RRVHLAPPPTWEGYDPSWN 
Fig. 1 Alignment of the GnTI protein sequences derived from
Arabidopsis thaliana (AtGnTI) and human (HuGnTI), using
ClustalW. Identical and similar residues are shaded black and
grey respectively. The N-glycosylation consensus site of A.
thaliana GnTI is indicated with an asterisk and the putative
transmembrane regions predicted by HMMTOP v2 are
underlined. The position of primers used for the construction
of the chimeric plant-human GnTI, are indicated with an arrow
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Elisa (Fig. 3a, b). The results from the western blots
show no specific qualitative differences in the patterns
of proteins labeled with complex glycans and therefore
glycosylation levels only differ quantitatively between
the lines (Fig. 3a). In the ChGnTIcgl lines the highest
signal was slightly lower than of the highest in the
AtGnTIcgl lines, but in all three the HuGnTIcgl plants
the level of proteins with complex glycans was very
low (Fig. 3b).
Relating transgene expression level to cgl1-1
complementation
To relate the level of complementation in the
different homozygous transgenic lines to the mRNA
expression level of the transgene, RNA isolated from
the selected lines was analyzed with real-time semi-
quantitative RT-PCR, using YFP-specific primers and
actin as an internal control. The results show a
comparable level of transgene expression in the three
AtGnTIcgl lines and two of the ChGnTIcgl lines
(Fig. 4a). In ChGnTIcgl line 6 the expression level of
the transgene was higher than in any of the other lines
(Fig. 4a), while in all three HuGnTIcgl lines the
expression was higher than in the three AtGnTIcgl
lines. Nevertheless, complementation in the three
HuGnTIcgl lines was lower than in the AtGnTIcgl
lines (Fig. 3) indicating that mRNA levels are not
limiting complementation by the HuGnTI gene.
Lines carrying the Arabidopsis, chimeric and
human GnTI-YFP fusion constructs with similar
mRNA expression levels (Fig. 4a: samples 1, 5 and
8) and lines with the highest mRNA expression level
(Fig. 4a: samples 1, 6 and 7) were used to relate the
mRNA level to the ectopically produced GnTI-YFP
fusion protein level and the level of complementa-
tion. Protein extracts were probed on a Western blot
with antibodies directed against YFP (Fig. 4b). In the
cgl1-1 lines transformed with AtGnTI-YFP (sample
1) and ChGnTI-YFP (sample 5 and 6) a band of
78 kDa was detected, corresponding to the mass of
the GnTI-YFP fusion protein. However, the GnTI-
YFP protein fusion product was not detected in
protein extracts from the two HuGnTIcgl lines
(Fig. 4b), even though a low level of complementa-
tion was observed in these plants (Fig. 3, lane 7–9).
This shows that HuGnTI-YFP protein is active in
these plants, but accumulates at relatively low levels.
In all extracts a protein fragment of *27 kDa was
detected, corresponding to free YFP, indicating that
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Fig. 2 Complementation of cgl1-1 plants. Proteins extracted
from primary T1 transformants from AtGnTI-YFPcgl, ChGnTI-
YFPcgl, HuGnTI-YFPcgl and wild type plants were probed in an
Elisa assay with serum directed at plant complex glycans.
Error bars represent SD
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Fig. 3 Complementation of cgl1-1 complemented plants.
Selected AtGnTI-YFPcgl (lane 1–3), ChGnTI-YFPcgl (lane 4–
6) and HuGnTI-YFPcgl (lane 7–9) T2 lines were analyzed by
immunoblotting (a) or Elisa (b) using a polyclonal anti-HRP
antibody that specifically recognizes complex type N-glycans.
Molecular weight markers are indicated on the left. Error bars
represent SD
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the fusion of the proteins with YFP is prone to
proteolytic cleavage.
When free YFP is cleaved from the GnTI-YFP
fusion proteins, the remainder of the membrane
bound GnTI protein may still contribute to GnTI
activity in cells. Therefore, the combined signal from
full length GnTI-YFP protein and the free YFP
protein band can be taken as a measure for the total
ectopic protein expression level. This combined
signal is similar for HuGnTIcgl (sample 7) and
AtGnTIcgl (sample 1), despite the approximately
five-fold difference in transgene mRNA levels in
these lines (Fig. 4a). In addition, the similar level of
ectopically produced protein in HuGnTI-YFPcgl and
AtGnTI-YFPcgl did not result in similar levels of
complementation (Fig. 3). The combined signal from
ChGnTI-YFP and free YFP was strongest in sample 6
(ChGnTI-YFP), consistent with the very high trans-
gene mRNA expression level in this line. However,
complementation level in this line was not as high as
in the cgl1-1 lines with homologous (AtGnTI)
complementation, indicating that the catalytic domain
of HuGnTI may be less active in plants.
Sub-cellular localization of the GnTI-YFP
fusion protein
We analyzed the sub-cellular localization of the
different GnTI-YFP fusion proteins in cells of leaves
from 10-day old transgenic seedlings by whole mount
confocal microscopy. As could be expected from the
expression levels in leaves, the YFP fluorescence
signal was most clearly detected in leaves of cgl1-1
seedlings transformed with AtGnTI-YFP or ChGnTI-
YFP. The YFP fluorescence in these plants displayed
a punctuated pattern, consistent with a Golgi-locali-
zation of the fusion protein (Fig. 5). No fluorescence
signal above background levels were detected in
leaves of cgl1-1 plants complemented with HuGnTI
(Fig. 5), consistent with the lack of detection on
western blot of intact HuGnTI-YFP fusion protein in
these plants (Fig. 4). The low fluorescence signal in
the stably transformed plants with HuGnTI-YFP
prevented accurate sub-cellular localization of the
gene product(s). Therefore, to confirm that the
HuGnTI-YFP expression construct can produce intact
fusion protein in plants and to obtain a better signal for
sub-cellular localization of this fusion protein in plant
cells, a transient protoplast expression assay was used.
The plant, human or chimeric GnTI protein were
fused to both YFP and CFP and the different
expression constructs were pair wise introduced into
Arabidopsis protoplasts through transfection. At 24 h
post-transfection the sub-cellular localization of the
resulting YFP and CFP fluorescence signal was
determined using confocal laser scanning microscopy
(CLSM). In addition, to confirm the putative Golgi
localization, co-localization experiments were per-
formed with the different GnTI-CFP fusion proteins
and the established (trans)Golgi marker STtmd-YFP
(Grebe et al. 2003).
Transient co-expression of the individual GnTI-
CFP expression constructs with the YFP-labeled
Golgi marker in Arabidopsis protoplasts showed a
distinct CFP signal, which localized to Golgi-like
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Fig. 4 GnTI-YFP expression in transgenic cgl1-1 lines. a
Quantification of the amount YFP transcript using real-time
PCR (black bars) in pooled seedlings of selected AtGnTI-
YFPcgl (1–3), ChGnTI-YFPcgl (4–6) and HuGnTI-YFPcgl (7–9)
lines. The RT-PCR results are expressed as the ratio between
the amounts of YFP versus the amount of actin transcript. b
Immunoblotting using monoclonal anti-GFP antibodies in
transgenic lines. The upper arrow indicates the position of
the GnTI-YFP fusion protein and the lower arrow indicates the
position of cleaved free YFP. Molecular weight markers are
indicated on the left
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compartments for all fusion proteins, including
HuGnTI-CFP (Fig. 6, CFP signal).
The fluorescence signal from HuGnTI in protop-
lasts indicates that, contrary to stably transformed
plants, the conditions of the transient expression
assay do allow the detection of this protein in plant
cells. Indeed, intact HuGnTI fusion protein in
protoplasts could now be detected by western blot
analysis (Fig. 7, lane 3). Results also show that the
*27 kDa protein band representing free YFP/CFP, is
mostly present in the medium fraction, indicating that
cleaved YFP/CFP is mostly secreted (Fig. 7, lane 4).
In protoplasts transfected with the AtGnTI-CFP and
STtmd-YFP, both full length fusion proteins are
detected in the protoplast fraction, while free CFP
(and/or YFP) was again detected in the medium
fraction (Fig. 7, lane 2).
All GnTI-YFP fusion proteins showed a similar
and high degree of co-localization with the Golgi
marker in the transfection assay (Fig. 6). Also, when
fluorescently labeled AtGnTI and ChGnTI were co-
expressed, the protein products showed a high degree
of co-localization (Fig. 8). However, when protop-
lasts were co-transfected with the AtGnTI-CFP and
the HuGnTI-YFP expression constructs together, the
CFP and YFP signal showed a lower degree of co-
localization to the same Golgi stacks: in addition to
double-labeled Golgi stacks, also Golgi stacks
labeled by only AtGnTI-CFP, as well as Golgi stacks
only labeled by the HuGnTI-YFP fusion protein were
Fig. 5 Localization of the GnTI-YFP fusion proteins in leaves
of 10 day old transgenic T2 seedlings by whole mount
microscopy. Left: light images leaf surface. Middle: fluorescent
images taken under equal filter and exposure settings. Right:
overlay light and fluorescent images. Seedlings expressing
AtGnTI-YFP or ChGnTI-YFP, displayed a punctate
fluorescence pattern consistent with a Golgi-localization. In
seedlings expressing HuGnTI-YFP either no or only very weak
punctuated fluorescence was detected. Similar results were
obtained for at least three independent transformed lines
expressing the different constructs
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detected (Fig. 8). Similar results were obtained in
transfection experiments when reciprocal labeled
fusion constructs (AtGnTI-YFP and HuGnTI-CFP)
were used. In contrast to when HuGnTI was trans-
fected alone, we noted that in many experiments the
fluorescence signal from the HuGnTI was low, or not
even detectable, when in the transfection the HuGnTI
was was co-expressed with the AtGnTI, regardless of
the CFP or YFP fluorescent label. Therefore, only
experiments in which protoplasts gave a clear dual
labeling were included in the score. Reduced fluo-
rescence signal due to lower HuGnTI accumulation
could lead to an overestimation of Golgi stacks only
labeled by AtGnTI fusion protein. However, also
Golgi stacks in the protoplasts are labeled only by the
HuGnTI, suggesting a sub-cellular localization that is
partly distinct from the sub-cellular localization of
AtGnTI in these transfection experiments.
Discussion
Multiple reasons for low complementation
efficiency of plant cgl1-1 by HuGnTI
Expression of heterologous glycosyltransferases in
plants is used to manipulate N-glycans on target
glycoproteins to advance the use of plants as
production platforms of therapeutic proteins. How-
ever, the factors that determine optimal activity of
heterologous enzymes within the context of the
endogenous plant glycosylation pathway are not well
Fig. 6 Co-localization of the GnTI-CFP fusion proteins with
the STtmd-YFP Golgi marker in wild-type A. thaliana
protoplasts by confocal laser scanning microscopy. Left column
represents different constructs showing the CFP signal, middle
column: fluorescence of STtmd-YFP construct; right column:
overlay of both staining patterns (green: CFP; red: YFP;
yellow: overlay CFP/YFP; blue: chlorophyll). The distinct
fluorescence signal from YFP and CFP in the protoplasts
showed good co-localization. White bar represents 20 lm.
(Color figure online)
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understood. Efficient expression of heterologous
glycosyltransferases depends not only on efficient
transcription and translation but also on their prote-
olitic stability and sub-Golgi localization in the new
host and possibly on interactions with other endog-
enous components of the glycosylation machinery of
the host, Here we have investigated with respect to
several characteristics the expression of human GnTI
in plants, which in previous experiments was shown
to have only limited activity in plant calli (Gomez
and Chrispeels 1994).
The activity of plant and human GnTI was
compared in a complementation assay using trans-
genic lines of the Arabidopsis mutant cgl1-1 (Figs. 2
and 3). The results confirm the low complementation
potential of the human GnTI gene in plants, as
previously shown by Gomez and Chrispeels (1994),
however, in their case the complementation potential
of human GnTI gene in Arabidopsis was not directly
related to expression and activity of the wild-type
Arabidopsis GnTI gene. Comparison of the mRNA
expression levels and the complementation potential
of fluorescently tagged AtGnTI, HuGnTI and ChGnTI
variants showed that all genes are well transcribed and
that the low complementation by HuGnTI must be due
to post-transcriptional limitations.
When lines with equal transgene mRNA steady
state level are compared (Fig. 4a, lanes 1, 5 and 8),
the Western blot analysis shows that the plant and
chimeric fusion protein product levels are very
similar, but from the HuGnTI-YFP protein no
product, neither fusion nor free YFP is detected.
This indicates a reduced stability of the HuGnTI-YFP
protein in plants and probably a reduced translation
of the HuGnTI-YFP mRNAs. Indeed, an approxi-
mately 6-fold higher transgene mRNA steady state
level was required (Fig. 4a, lane 1 and 7) to get
similar levels of ectopically produced protein prod-
ucts in the AtGnTI-YFPcgl and HuGnTI-YFPcgl
plants, as indicated by the combined signal of the
fusion protein and free YFP (Fig. 4b, lane 1 and 7).
However, this did not result in equal levels of
complementation of the complex glycan levels in
these lines (Fig. 3a, lane 1 and 7).
When the CTS domain of HuGnTI was replaced
by the AtGnTI CTS domain the average comple-
mentation level in 9 independent transformants was
almost equal to that of the lines transformed with the
plant GnTI (Fig. 2), However, when lines with equal
expression levels were compared (Fig. 4a, lane 1 and
5), complementation efficiency of the ChGnTI-YFP
was shown to be significantly higher than with
HuGnTI-YFP but not as high as that of AtGnTI-
YFP (Fig. 3, lanes 1 and 5). Even though ChGnTI-
YFP and AtGnTI-YFP were targeted with high
degree to the same sub-cellular compartments
(Fig. 6), the catalytic domain of HuGnTI is appar-
ently enzymatically not as active in plants as that of
plant GnTI.Because the sequence of human and
chimeric mRNA is very similar (83% identical) and
have identical 50 untranslated sequences, we assume a
similar translational efficiency of these two mRNA’s
in plants. As equal ChGnTI and AtGnTI mRNA
steady state levels resulted in equal protein steady
state levels, we therefore assume that HuGnTI
mRNA is as efficiently translated in plants as AtGnTI
mRNA and the reduced activity of HuGnTI is
therefore ascribed to post-translational characteristics
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Fig. 7 Western blot analysis of protoplasts from two separate
co-transfections. Proteins were extracted from the protoplast
(p) and the medium (m) from a co-transfection assay with the
plant GnTI-CFP and the YFP-Golgi marker (lane 1 and 2) and
a co-transfection with HuGnTI-YFP and HuGnTI-CFP (lane 3
and 4) and used for western blotting with antibodies against
GFP. The position of the GnTI fusion proteins (a), the YFP-
Golgi marker (b) and the free cleaved YFP/CFP (c) is indicated
by the arrows on the left. Molecular weight markers are
indicated on the left
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such as the apparent reduced protein stability, mis-
targetting or reduced activity of the catalytic domain
of HuGnTI.
A factor which may contribute to the instability of
HuGnTI protein in plants is the relatively high score
for cleavage of the transmembrane anchor according
to the signal peptide sequence prediction. Cleavage of
the transmembrane anchor would result in a soluble
form of HuGnTI-YFP, which may not be retained
efficiently in the Golgi.
Subcellular localization of plant, chimeric
and human GnTI
Localization studies in stably transformed plants
showed a clear punctuate fluorescence signal in the
Fig. 8 Co-localization of the AtGnTI or/and the HuGnTI fusion
protein with either the YFP and CFP marker in wild-type A.
thaliana protoplasts by confocal laser scanning microscopy. Left
column represents constructs showing the CFP signal, middle
column: fluorescence of GnTI-YFP construct, right column:
overlay of both staining patterns (yellow color indicates overlay)
combined with the chlorophyll signal (blue color). White bar
represents 20 lm. (Color figure online)
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ChGnTIcgl and AtGnTIcgl lines, indicative of Golgi
localization. However, no apparent Golgi-localized
YFP signal was detected in transgenic plants express-
ing HuGnTI-YFP (Fig. 5). We reasoned that in a
transient expression assay like with plant protoplasts,
the transient expression pulse from the high copy
number of the introduced expression vector, com-
bined with reduced protein degradation in protop-
lasts, may be sufficient to allow for detection of the
HuGnTI-YFP fusion product. Indeed, transfection
with the HuGnTI-YFP expression construct resulted
in a clear fluorescence signal localized to distinct
Golgi stacks, which were demonstrated to be Golgi
stacks by co-transfection with a marker protein
(Fig. 6). In addition, also the full length HuGnTI-
YFP protein was now detected in protoplast protein
extracts by western blotting, while in the medium a
fraction of free YFP was detected (Fig. 7).
We used co-localization studies to determine if
AtGnTI and HuGnTI target the same subcellular
compartments in plant cells. In our experimental set-
up, co-localization studies can clearly distinguish
between cytosolic, ER and Golgi stacks, but not
between individual cisternae. When identical GnTI
proteins, fused to either YFP or CFP, were co-
expressed in protoplasts, a high degree of co-local-
ization to the same Golgi stacks was observed
(Fig. 8), indicating that the relatively high gene
dosage that is used in the protoplast transfection
assays does not lead to alternative targeting of
differentially labeled proteins per se. Indeed, also
when fluorescently labeled AtGnTI and ChGnTI were
co-expressed, the protein products showed a high
degree of co-localization (Fig. 8). In contrast, when
AtGnTI-YFP and HuGnTI-CFP were co-expressed in
the same protoplasts (using the same gene dosage in
the transfection), limited co-localization of these two
different forms of the GnTI was observed (Fig. 8).
Moreover, similar results were obtained when recip-
rocally labeled proteins were used for the AtGnTI/
ChGnTI and AtGnTI/HuGnTI co-localization studies
(data not shown). We noted that the signal from the
fluorescently labeled HuGnTI was consistently low
when expressed together with the plant GnTI fusion
protein, but not when co-expressed with the Golgi
marker or with reciprocally labeled HuGnTI. It has
been reported that plant cells appear to have a high
flexibility in using the ER to assemble novel organ-
elles (Lisenbee et al. 2003; Masclaux et al. 2005)
which could be related to the partial unique locali-
zation of HuGnTI in the protoplast transient expres-
sion assay. If and how this further relates to the
reduced complementation activity of HuGnTI in
stably transformed plants would require additional
experiments with new transgenic lines with suffi-
ciently high expression and high resolution (electro-)-
microscopical studies.
In summary, our results show that the low
complementation capacity of the human GnTI is
caused by post-transcriptional limitations. The low
activity of HuGnTI in plant cells can thus be
explained by reduced stability of HuGnTI protein
compared to plant GnTI, including cleavage of the
catalytic domain from the membrane anchor and
possibly by a potential of HuGnTI to target Golgi
stacks other than those targeted by AtGnTI. The data
obtained with ChGnTI show that these differences
can be ascribed to differences in the CTS region and
in addition that the catalytic domain of HuGnTI
performs less in plants than the plant catalytic
domain.
Materials and methods
Plant materials and growth conditions
Seeds of Arabidopsis thaliana lines were sown on
9 cm 0.8% daishun agar Petri dishes and placed in a
cold room at 4C for 2 days in the dark to promote
uniform germination. Plants were grown in soil in a
greenhouse with a 16 h day/8 h dark cycle at a
temperature of 22C.
Construction of GFP/CFP-tagged GnTI vectors
Arabidopsis and human GnTI was PCR amplified
using Platinum Pfx polymerase (Invitrogen) and
primers flanking the coding region. The primers used
for cloning the AtGnTI were AtGnT-F (50-GTGACA-
GATCTATGGCGAGGATCTCGTGTGACTT G-30)
and AtGnT-R (50-GTGACCCATGGAATTTCGAAT
TCCAAGCTGC-30) which contain a BglII and NcoI
site respectively, with the NcoI site deleting the
original stop codon. The primers used for cloning the
HuGnTI were FW13 HuGnT (50-GTGACGGTCTC
AGATCTATGCTGAAGAAGCAGTCTGCA-30) and
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RV10 HuGnT (50- GTGACGGTCTCACATGCGAT
TCCAGCTAGGATCAT-30 which both contain a BsaI
site that after digest leave a BglII and NcoI overhang
respectively, with the NcoI site deleting the original
stop codon. The full-length GnTIs cDNA was inserted
into the BglII and NcoI site of the pMON999-CFP/YFP
(Monsanto, St. Louis, MO) transfection vector.
Construction of chimeric plant/human GnTI
A chimeric construct of GnTI was generated by
fusing the Arabidopsis GnTI CTS domain (amino
acid 1–102) and the mammalian GnTI catalytic
domain (amino acid 102–445). The putative CTS
region of Arabidopsis was amplified by PCR using
Platinum pfx Polymerase (Invitrogen) with the primers
AtGnTI CTS-F (50GGTCTCAGATCTATGGCGA
GGATCTCGT GTGACTTG-30) and AtGnTI CTS-R
(50-AACTCACTCAAGGTGGACAGGCGGTGAT
T-30). The fragment encoding the catalytic domain of
the human GnTI was amplified using the primers
HuGnTI cat-F (50-GGTGGACAGGCGGTGATTCC-
CATCCTGG-30) and RV10 HuGnTI (50- GTGAC
GGTCTCACATGCGATTCCAGCTAGGATCAT-30).
The AthGNTI CTS-R primer and the HU-CAT primer
were overlapping in the sequence 50-GGTGGACAG
GCGGTGATT-30. The PCR products were purified
using the QIAquick PCR Purification Kit (Qiagen).
The CTS domain and the human catalytic domain
were hybridized together using the PCR products as
megaprimers in a second PCR, together with the
AtGnT CTS-F and RV10 HuGnT primers for the
generation of the full length chimeric GnTI. The
sequence of the fusion product was verified by DNA
sequencing of the cloned PCR product and the full-
length ChGnTI cDNA was inserted into the BglII and
NcoI site of pMON999-CFP/YFP (Monsanto, St.
Louis, MO) transfection vector.
Construction of the binary vectors
The pMON vectors with the AtGnTI-YFP and
ChGnTI-YFP constructs were digested by HindIII
and SmaI, and the resulting 35S-GnTI-YFP DNA
fragments were isolated and ligated into the HindIII
and SmaI sites of the pBin? vector. For construction
of the HuGnTI expression vector, the pMON vector
of the HuGnTI-YFP construct was cut by Hind III
and Sca I in order to isolate the 35S promoter-
HuGnTI CTS domain DNA fragment. This fragment
was used to replace the 35S promoter-AtGnTI CTS
domain in the pBin? with ChGnTI-YFP.
Transformation of Arabidopsis
pBinplus constructs containing the GnTI-YFP cas-
settes were transferred to Agrobacterium tumefaciens
AGL-0 by triparental mating using the E.Coli
pRK2013 helper plasmid. Arabidopsis plants were
transformed by immersion in the bacteria suspension
culture. Seeds from transformed plants were selected
by growing on plates containing MS powder (4.4 g/l),
sucrose (10 g/l) and Daishin agar (8 g/l) with kana-
mycin (50 lg/ml) as selective marker. Seeds were
germinated and grown on selective medium for
1–2 weeks (25C long day conditions). The putative
transformants were transferred to soil and grown
using standard conditions (16 h day/8 h dark).
Arabidopsis protoplast isolation and transfection
Arabidopsis mesophyll protoplasts were prepared and
transfected according to Aker et al. (2006). Protoplasts
were investigated for CFP/YFP expression with a
confocal laser scanning microscope 510 as described
before (Shah et al. 2002) (Carl Zeiss, Jena, Germany).
SDS–PAGE and immunoblotting
Plant material was ground in liquid nitrogen, resus-
pended in 10 ll phosphate-buffered saline (137 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM
KH2PO4, pH 7.4) per mg of plant material and
centrifuged. The protein concentration of each sam-
ple was measured using the Bio-Rad RC/DC protein
assay using the manufacturer’s instructions and 5 ug
of total protein from each sample was mixed with
SDS–polyacrylamide gel electrophoresis (PAGE)
loading buffer, denatured at 95C for 5 min and
subjected to SDS–PAGE (8 or 12.5%) under reducing
conditions. Western blotting was performed using
PVDF membranes, blocked with 5% (w/v) non-fat
dry milk in Tris-buffered saline (TBS, 20 mM Tris–
HCl, pH 7.6, 137 mM NaCl) with 0.05% Tween20.
The membranes were probed with either anti-HRP
(1:2000; Sigma) or anti-GFP (1:5000; Roche). Detec-
tion of bound primary antibodies was performed with
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BCIP/NBT or after incubation with goat anti-rabbit
antibodies.
Elisa
Microtiter plates were coated with equal amounts of
total protein extracts from transformed cgl1-1 seed-
lings overnight at 4C in 0.1 M sodium carbonate
buffer, pH 9.6. The plates were washed with phos-
phate-buffered saline (PBS) containing 0.05% Tween
20 and blocked with PBS-T containing 5% skimmed
milk for 1 h at RT. After the washing the plates were
incubated for 1 h at RT with anti-HRP diluted 1:2,000.
Detection of bound primary antibodies was performed
with AP substrate after incubation with goat anti-rabbit
antibodies.
RNA isolation and RT-PCR analysis
RNA was extracted from transformed cgl1-1 seedlings
using TriPure isolation reagent (Roche) and the
concentration was measured with a NanoDrop ND-
1000 UV–Vis Spectrophotometer. 1 lg of RNA was
used to make cDNA with Taqman Reverse Transcript
reagent (Applied Biosystems). Quantitative real-time
PCR was performed using the Bio-Rad iQSYBR Green
Supermix single color detection system. Briefly, after a
3 min denaturation at 94C, 40 cycles of 15 s at 94C
and 30 s at 60C were followed by a melting curve
gradient. No template controls served as blanks and ß-
Actin was used as a reference gene. Samples were run
in triplicate, averaged, and relative gene expression
was calculated using the 2-ddt method (Livak and
Schmittgen 2001). Primers were designed using Bea-
con Designer (Biosoft International, Palo Alto, USA)
and ordered by Invitrogen. The primer pair YFP-F (50-
TTCAAGGAGGACGGCAAC-30) and YFP-R (50-GG
TGTTCTGCTGGTAGTG-30) was used for the
experiment.
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